We are proud to announce that Dr Sigen A was awarded an SFI Industrial Fellowship in association with Blafar Ltd. to develop and support industry-academia research partnerships.

In this SFI Industrial Fellowship Project, Dr Sigen A will collaborate with industry partner Blafar Ltd. to develop and commercialize UV cross-linkable hyperbranched poly(β-amino esters) modified with dopamine as a new generation of safety-enhanced tissue adhesives for high-efficiency sternum bonding.

Blafar Ltd. will greatly benefit from this high value and in-depth research closely aligned with the company’s strategic interests.